Gravel Pharma Private Limited

Founded in 2013 and headquartered in Maharashtra, India.

2013 | Latur, Maharashtra (India) | Active
Last Updated:

Gravel Pharma Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.97 M
  • Company Age 11 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 2.46%
  • Profit Growth 1.41%
  • Ebitda -2.93%
  • Net Worth -20.02%
  • Total Assets -12.21%

About Gravel Pharma

Gravel Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2013 and has a history of 11 years and 11 months. Its registered office is in Latur, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.97 M, as per Ministry of Corporate Affairs (MCA) records.

Vishnudas Bahndari, Uttam Deshmane, Sanjay Jogdanad, and One other member serve as directors at the Company.

Company Details

  • Location

    Latur, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999MH2013PTC244491

  • Company No.

    244491

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Jun 2013

  • Date of AGM

    20 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma
Company report

Gravel Pharma Private Limited

Explore comprehensive data for Gravel Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Gravel Pharma?

Board Members (4)

NameDesignationAppointment DateStatus
Vishnudas Bahndari Country flag representing In Director 14-Jun-2013Current
Uttam Deshmane Country flag representing In Director 14-Jun-2013Current
Sanjay Jogdanad Country flag representing In Director 14-Jun-2013Current
Rahul Laturiya Country flag representing In Director 14-Jun-2013Current

Financial Performance of Gravel Pharma.

Gravel Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.46% increase. The company also saw a slight improvement in profitability, with a 1.41% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.02%.

Gravel Pharma revenue growth over time
Gravel Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2.46%
Revenue from Operations
2.01%
Total Assets
-12.21%
Profit or Loss
1.41%
Net Worth
-20.02%
EBITDA
-2.93%

What is the Ownership and Shareholding Structure of Gravel Pharma?

In 2023, Gravel Pharma had a promoter holding of 18.52% and a public holding of 81.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Gravel Pharma?

Unlock and access historical data on people associated with Gravel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Gravel Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gravel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gravel Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Gravel Pharma

Recent activity within the organization

  • Annual General Meeting

    Gravel Pharma Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Gravel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Vishnudas Dwarkadas Bahndari was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 11 months .

  • Director Appointment

    Uttam Dagdurao Deshmane was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 11 months .

  • Director Appointment

    Sanjay Tukaram Jogdanad was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 11 months .

  • Director Appointment

    Rahul Nandkishor Laturiya was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 11 months .

Frequently asked questions

  • What is the Incorporation or founding date of Gravel Pharma Private Limited?

    Gravel Pharma Private Limited was incorporated on 14 Jun 2013.

  • What is authorized share capital and paid-up capital of Gravel Pharma Private Limited?

    The authorized share capital of Gravel Pharma Private Limited is ₹ 2.50 M and paid-up capital is ₹ 0.97 M.

  • Who are the current board members & directors of Gravel Pharma Private Limited?

    Currently 4 directors are associated with Gravel Pharma Private Limited.

    • Vishnudas Dwarkadas Bahndari
    • Uttam Dagdurao Deshmane
    • Sanjay Tukaram Jogdanad
    • Rahul Nandkishor Laturiya

  • What is the registered address of Gravel Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Gravel Pharma Private Limited is Bhakti Nagar, Tq. Dist. India, Latur, Maharashtra, 413512.

  • What is the corporate identification number (CIN) and company number of Gravel Pharma Private Limited?

    The corporate identification number (CIN) of Gravel Pharma Private Limited is U74999MH2013PTC244491 and the company number is 244491 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Gravel Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Gravel Pharma Private Limited has risen by 2.46%.

  • What change has been observed in the net worth of Gravel Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Gravel Pharma Private Limited has experienced an downturn of -20.02%.

  • When was the last Balance Sheet of Gravel Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Gravel Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development